| Literature DB >> 24241036 |
Alessandra Vacca1, Christophe Meune1, Jessica Gordon1, Lorinda Chung2, Susanna Proudman1, Shervin Assassi1, Mandana Nikpour1, Tatiana S Rodriguez-Reyna1, Dinesh Khanna1, Robert Lafyatis1, Marco Matucci-Cerinic1, Oliver Distler1, Yannick Allanore3.
Abstract
Signs and symptoms of arrhythmias or conduction defects are frequently reported in patients with SSc. These rhythm disorders may have several origins (i.e., related to primary heart involvement, pericardial disease, valvular regurgitation or pulmonary arterial hypertension) and may negatively affect the overall prognosis of these patients. It is therefore important to identify patients at high risk for cardiac arrhythmias with a complete cardiological evaluation and to identify the underlying heart disease, including SSc-related myocardial involvement. In addition, some therapeutic options in SSc patients may differ from those recommended in other populations.Entities:
Keywords: arrhythmias; cardiac involvement; conduction defects; mortality; systemic sclerosis
Mesh:
Substances:
Year: 2013 PMID: 24241036 PMCID: PMC4065005 DOI: 10.1093/rheumatology/ket377
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580